Trem2 knockout mice exhibited decreased recruitment of myeloid regulatory cells in tumours that was associated with increased T and NK cell functionality and reduced tumour growth [174], thus highlighting the potential therapeutic effect of targeting Trem2 signalling to reduce immune suppression activity. Here, TREM2 is linked to neoplasm.